{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:38:20Z","timestamp":1793374700068,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Microvascular obstruction (MVO) remains a major complication following coronary reperfusion, but its pathogenesis is poorly defined. We evaluated myocardial platelet activation and thrombosis using fluorine-18-labelled GP1 ([18F]GP1) positron emission tomography (PET) in patients with anterior ST-segment elevation myocardial infarction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In a single-centre observational cohort study, 100 patients with acute anterior ST-segment elevation myocardial infarction underwent hybrid cardiac [18F]GP1 PET and magnetic resonance (MR) imaging with gadolinium enhancement and repeat imaging at 3\u20136 months. Myocardial [18F]GP1 uptake was quantified using target-to-background ratio (TBRmax) and percentage myocardial uptake (burden) and compared with MR measures of infarction, MVO and adverse ventricular remodelling. One hundred patients (60 \u00b1 10 years, 91% male) underwent [18F]GP1 PET\/MR imaging at a median of 13 days following index presentation. Increased myocardial [18F]GP1 uptake was observed in 44% of participants (TBRmax 1.89 \u00b1 0.50). All 40 patients with MR-defined MVO demonstrated myocardial [18F]GP1 uptake. Myocardial [18F]GP1 uptake burden correlated with (\u03c1 = 0.84; P &amp;lt; 0.001), and exceeded (by 18%), MR-defined burden of MVO. Myocardial [18F]GP1 uptake was associated with infarct size, lower left ventricular ejection fraction and longer time-to-reperfusion. Angiographic no-reflow was the strongest independent association of MVO (adjusted odds ratio 16.15; P &amp;lt; 0.001). Persistent myocardial [18F]GP1 uptake at follow up (22%, 7\/32) was associated with lower left ventricular ejection fraction. Resolution of cardiac MR-defined MVO was observed in 78% of patients at follow-up and was universally concordant with resolution of myocardial [18F]GP1 uptake.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MVO following ST-segment elevation myocardial infarction is universally associated with myocardial platelet activation, extending beyond structural abnormalities identified by cardiac MR. These findings are consistent with an important mechanistic contribution of platelet-mediated microvascular thrombosis to no-reflow and MVO, highlighting a potentially targetable biological pathway in a condition for which effective therapies remain elusive.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjci\/jeag225","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:52:39Z","timestamp":1787226759000},"page":"1939-1952","source":"Crossref","is-referenced-by-count":1,"title":["Platelet activation and thrombosis in microvascular obstruction"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1991-0017","authenticated-orcid":false,"given":"Craig","family":"Balmforth","sequence":"first","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, University of Edinburgh, Institute for Neuroscience and Cardiovascular Research, Edinburgh, United Kingdom of Great Britain & Northern \u00a0","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7779-5276","authenticated-orcid":false,"given":"Alessandro","family":"Giaj Levra","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, University of Edinburgh, Institute for Neuroscience and Cardiovascular Research, Edinburgh, United Kingdom of Great Britain & Northern \u00a0","place":["Ireland"]},{"name":"Department of Biomedical Sciences, Humanitas University, Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2833-5980","authenticated-orcid":false,"given":"Beth","family":"Whittington","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, University of Edinburgh, Institute for Neuroscience and Cardiovascular Research, Edinburgh, United Kingdom of Great Britain & Northern \u00a0","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0465-7065","authenticated-orcid":false,"given":"Aidan","family":"Morgan","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, University of Edinburgh, Institute for Neuroscience and Cardiovascular Research, Edinburgh, United Kingdom of Great Britain & Northern \u00a0","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5355-3109","authenticated-orcid":false,"given":"Mark G","family":"Macaskill","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, University of Edinburgh, Institute for Neuroscience and Cardiovascular Research, Edinburgh, United Kingdom of Great Britain & Northern \u00a0","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0038-043X","authenticated-orcid":false,"given":"Evangelos","family":"Tzolos","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, University of Edinburgh, Institute for Neuroscience and Cardiovascular Research, Edinburgh, United Kingdom of Great Britain & Northern \u00a0","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0687-6641","authenticated-orcid":false,"given":"Alex J","family":"Jordan","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, University of Edinburgh, Institute for Neuroscience and Cardiovascular Research, Edinburgh, United Kingdom of Great Britain & Northern \u00a0","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4036-9043","authenticated-orcid":false,"given":"Tariq","family":"Ramtoola","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, University of Edinburgh, Institute for Neuroscience and Cardiovascular Research, Edinburgh, United Kingdom of Great Britain & Northern \u00a0","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Clark","sequence":"additional","affiliation":[{"name":"Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, United Kingdom of Great Britain & Northern \u00a0","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1651-171X","authenticated-orcid":false,"given":"Michelle","family":"Rooney","sequence":"additional","affiliation":[{"name":"Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, United Kingdom of Great Britain & Northern \u00a0","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9866-7257","authenticated-orcid":false,"given":"Christophe","family":"Lucatelli","sequence":"additional","affiliation":[{"name":"Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, United Kingdom of Great Britain & Northern \u00a0","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2777-5071","authenticated-orcid":false,"given":"Edwin J R","family":"van Beek","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, University of Edinburgh, Institute for Neuroscience and Cardiovascular Research, Edinburgh, United Kingdom of Great Britain & Northern \u00a0","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6110-938X","authenticated-orcid":false,"given":"Piotr J","family":"Slomka","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Centre, Los Angeles, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L","family":"Sellers","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, BC ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7583-8201","authenticated-orcid":false,"given":"Norman","family":"Koglin","sequence":"additional","affiliation":[{"name":"Lantheus Germany GmbH, Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5052-6586","authenticated-orcid":false,"given":"Andrew W","family":"Stephens","sequence":"additional","affiliation":[{"name":"Lantheus Germany GmbH, Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9865-9302","authenticated-orcid":false,"given":"Iris","family":"Hardewig","sequence":"additional","affiliation":[{"name":"Lantheus Germany GmbH, Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7971-4628","authenticated-orcid":false,"given":"David E","family":"Newby","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, University of Edinburgh, Institute for Neuroscience and Cardiovascular Research, Edinburgh, United Kingdom of Great Britain & Northern \u00a0","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3556-2428","authenticated-orcid":false,"given":"Michelle C","family":"Williams","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, University of Edinburgh, Institute for Neuroscience and Cardiovascular Research, Edinburgh, United Kingdom of Great Britain & Northern \u00a0","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9847-5917","authenticated-orcid":false,"given":"Marc R","family":"Dweck","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, University of Edinburgh, Institute for Neuroscience and Cardiovascular Research, Edinburgh, United Kingdom of Great Britain & Northern \u00a0","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,30]]},"reference":[{"key":"2026103011072159900_jeag225-B1","doi-asserted-by":"crossref","first-page":"1620204","DOI":"10.3389\/fcvm.2025.1620204","article-title":"Coronary microvascular dysfunction in post-PCI target vessels: a systematic review and meta-analysis of prevalence and associated outcomes","volume":"12","author":"Li","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"2026103011072159900_jeag225-B2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"2026103011072159900_jeag225-B3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ahj.2003.11.010","article-title":"Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial","volume":"147","author":"Prasad","year":"2004","journal-title":"Am Heart J"},{"key":"2026103011072159900_jeag225-B4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cvr\/cvz301","article-title":"Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction","volume":"116","author":"Konijnenberg","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2026103011072159900_jeag225-B5","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","article-title":"Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials","volume":"38","author":"de Waha","year":"2017","journal-title":"Eur Heart J"},{"key":"2026103011072159900_jeag225-B6","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.jcmg.2021.02.023","article-title":"Coronary microvascular dysfunction assessed by pressure wire and CMR after STEMI predicts long-term outcomes","volume":"14","author":"Scarsini","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026103011072159900_jeag225-B7","doi-asserted-by":"crossref","first-page":"108995","DOI":"10.1016\/j.pharmthera.2026.108995","article-title":"Therapeutic interventions for coronary microvascular obstruction after acute myocardial infarction: developments and challenges","volume":"282","author":"Maino","year":"2026","journal-title":"Pharmacol Ther"},{"key":"2026103011072159900_jeag225-B8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024930","article-title":"Is platelet reactivity a therapeutic target to limit microvascular obstruction?","volume":"11","author":"Carberry","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026103011072159900_jeag225-B9","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1136\/hrt.2005.064485","article-title":"Management of microvascular dysfunction and reperfusion injury","volume":"91","author":"Prasad","year":"2005","journal-title":"Heart"},{"key":"2026103011072159900_jeag225-B10","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/cvr\/cvz070","article-title":"Platelets in cardiac ischaemia\/reperfusion injury: a promising therapeutic target","volume":"115","author":"Ziegler","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2026103011072159900_jeag225-B11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.020973","article-title":"Post\u2013ST-segment\u2013elevation myocardial infarction platelet reactivity is associated with the extent of microvascular obstruction and infarct size as determined by cardiac magnetic resonance imaging","volume":"11","author":"Massalha","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026103011072159900_jeag225-B12","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1161\/01.CIR.85.5.1699","article-title":"Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction","volume":"85","author":"Ito","year":"1992","journal-title":"Circulation"},{"key":"2026103011072159900_jeag225-B13","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1172\/JCI107898","article-title":"The \u201cno-reflow\u201d phenomenon after temporary coronary occlusion in the dog","volume":"54","author":"Kloner","year":"1974","journal-title":"J Clin Invest"},{"key":"2026103011072159900_jeag225-B14","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/eurheartj\/ehv484","article-title":"Coronary microvascular obstruction in acute myocardial infarction","volume":"37","author":"Niccoli","year":"2015","journal-title":"Eur Heart J"},{"key":"2026103011072159900_jeag225-B15","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2967\/jnumed.116.188896","article-title":"(18)F-GP1, a novel PET tracer designed for high-sensitivity, low-background detection of thrombi","volume":"58","author":"Lohrke","year":"2017","journal-title":"J Nucl Med"},{"key":"2026103011072159900_jeag225-B16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2967\/jnumed.118.212084","article-title":"Glycoprotein IIb\/IIIa receptor imaging with (18)F-GP1 positron emission tomography for acute venous thromboembolism: an open-label, non-randomized, first-in-human phase 1 study","volume":"60","author":"Kim","year":"2018","journal-title":"J Nucl Med"},{"key":"2026103011072159900_jeag225-B17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13550-018-0471-8","article-title":"A phase 1, first-in-human study of (18)F-GP1 positron emission tomography for imaging acute arterial thrombosis","volume":"9","author":"Chae","year":"2019","journal-title":"EJNMMI Res"},{"key":"2026103011072159900_jeag225-B18","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jcmg.2021.11.015","article-title":"18F-GP1 positron emission tomography and bioprosthetic aortic valve thrombus","volume":"15","author":"Bing","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026103011072159900_jeag225-B19","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jcmg.2022.10.002","article-title":"Noninvasive in vivo coronary artery thrombus imaging","volume":"16","author":"Tzolos","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026103011072159900_jeag225-B20","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/ATVBAHA.122.318204","article-title":"Noninvasive in vivo thrombus imaging in patients with ischemic stroke or transient ischemic attack-brief report","volume":"43","author":"Whittington","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026103011072159900_jeag225-B21","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"2026103011072159900_jeag225-B22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and Nomenclature for tomographic imaging of the heart","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"2026103011072159900_jeag225-B23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12350-011-9496-3","article-title":"Automated quantitative rb-82 3D PET\/CT myocardial perfusion imaging: normal limits and correlation with invasive coronary angiography","volume":"19","author":"Nakazato","year":"2012","journal-title":"J Nucl Cardiol"},{"key":"2026103011072159900_jeag225-B24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jacc.2024.10.103","article-title":"Myocardial fibroblast activation after acute myocardial infarction: a positron emission tomography and magnetic resonance study","volume":"85","author":"Barton","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026103011072159900_jeag225-B25","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jacc.2020.01.041","article-title":"Low-dose alteplase during primary percutaneous coronary intervention according to ischemic time","volume":"75","author":"McCartney","year":"2020","journal-title":"JACC"},{"key":"2026103011072159900_jeag225-B26","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1093\/eurheartj\/ehae587","article-title":"Glycoprotein IIb\/IIIa inhibitors in acute myocardial infarction and angiographic microvascular obstruction: the REVERSE-FLOW trial","volume":"45","author":"Eitel","year":"2024","journal-title":"Eur Heart J"},{"key":"2026103011072159900_jeag225-B27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCULATIONAHA.124.068938","article-title":"Effect of cangrelor on infarct size in ST-segment\u2013elevation myocardial infarction treated by primary percutaneous coronary intervention: a randomized controlled trial (the PITRI trial)","volume":"150","author":"Bulluck","year":"2024","journal-title":"Circulation"},{"key":"2026103011072159900_jeag225-B28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jcmg.2018.02.018","article-title":"Index of microcirculatory resistance as a tool to characterize microvascular obstruction and to predict infarct size regression in patients with STEMI undergoing primary PCI","volume":"12","author":"Maria","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026103011072159900_jeag225-B29","doi-asserted-by":"crossref","first-page":"e017645","DOI":"10.1161\/CIRCIMAGING.124.017645","article-title":"Clinical impact of persistent microvascular obstruction in CMR after reperfused STEMI","volume":"18","author":"Troger","year":"2025","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeag225\/70833469\/jeag225.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/27\/11\/1939\/70833469\/jeag225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/27\/11\/1939\/70833469\/jeag225.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:07:33Z","timestamp":1793372853000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/27\/11\/1939\/8772906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,30]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,8,30]]},"published-print":{"date-parts":[[2026,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeag225","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,8,30]]}}}